title: Effect of troglitazone on lipoprotein(a) levels in obese subjects.
authors.forename: C J
authors.initials: CJ
authors.lastname: Tack
authors.forename: P
authors.initials: P
authors.lastname: Smits
authors.forename: P N
authors.initials: PN
authors.lastname: DeMacker
authors.forename: A F
authors.initials: AF
authors.lastname: Stalenhoef
mesh_terms: D002839:Chromans / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D017270:Lipoprotein(a) / Q000097:blood*; D009765:Obesity; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D000077288:Troglitazone
chemical_list: D002839:Chromans; D007004:Hypoglycemic Agents; D017270:Lipoprotein(a); D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone